Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this population
- PMID: 40378601
- PMCID: PMC12131004
- DOI: 10.1016/j.htct.2025.103846
Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this population
Abstract
There is no physiological mechanism for the excretion of iron in humans, and excess iron may lead to severe tissue damage if not adequately treated. Iron overload can be caused by genetic factors (hemochromatosis) or acquired conditions (e.g., ineffective erythropoiesis, transfusions, iatrogenic iron treatment, viral hepatitis, alcohol intake, severe liver disease, metabolic dysfunction), and, in many cases, by a conjunction of these factors. Historically, guidelines for the genetic investigation of patients with iron overload have been based on data obtained from Caucasian individuals in Europe and North America. However, due to the genetic heterogeneity of iron overload gene mutations worldwide, these recommendations might not be applicable to other ethnic groups. This study analyzed previously published genetic data obtained from Brazilian patients with iron overload and found a relevant but small prevalence of HFE C282Y/C282Y patients when compared to European populations, while mutations of the TFR2, SCL40A1, HJV, HAMP, BMP6 and SLC11A1 genes seem to be important. This study proposes an adapted algorithm for the investigation and management of iron overload in Brazil.
Keywords: Ethnic groups; Gene mutations; Genetic heterogeneity; Iron overload.
Copyright © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Conflicts of interest The authors declare no conflicts of interest.
Figures

Similar articles
-
Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.Blood Cells Mol Dis. 2011 Apr 15;46(4):302-7. doi: 10.1016/j.bcmd.2011.02.008. Blood Cells Mol Dis. 2011. PMID: 21411349
-
[Hereditary and acquired iron overload].Nephrol Ther. 2006 Nov;2 Suppl 5:S304-12. Nephrol Ther. 2006. PMID: 17373275 French.
-
Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.Clinics (Sao Paulo). 2009;64(9):837-41. doi: 10.1590/S1807-59322009000900003. Clinics (Sao Paulo). 2009. PMID: 19759876 Free PMC article.
-
Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.Gastroenterology. 2010 Aug;139(2):393-408, 408.e1-2. doi: 10.1053/j.gastro.2010.06.013. Epub 2010 Jun 11. Gastroenterology. 2010. PMID: 20542038 Review.
-
[Iron overload disease: recent findings].Ann Ital Med Int. 2004 Jul-Sep;19(3):145-54. Ann Ital Med Int. 2004. PMID: 15529941 Review. Italian.
References
-
- Brissot P., Loreal O. Hemochromatoses. J Hepatol. 2021;75(3):723–724. - PubMed
-
- Adams P.C., Jeffrey G., Ryan J. Haemochromatosis. Lancet. 2023;401(10390):1811–1821. - PubMed
-
- European Association for the Study of the Liver Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022;77(2):479–502. - PubMed
-
- Pietrangelo A. Hereditary hemochromatosis–a new look at an old disease. N Engl J Med. 2004;350(23):2383–2397. - PubMed
Publication types
LinkOut - more resources
Full Text Sources